HOME >> BIOLOGY >> NEWS
'Smart gene therapy' protects against damage from heart attack

DURHAM, N.C. — Early intervention with a novel kind of "smart gene therapy" might effectively prevent the organ damage commonly suffered by heart attack victims, suggests a new animal study by researchers at Brigham and Women's Hospital in Boston and Duke University Medical Center. The therapy combines a therapeutic gene with a genetic "sensor" that recognizes and responds to the oxygen deprivation that follows the reduced blood flow, or ischemia, from coronary artery disease and heart attack.

As soon as the oxygen declines, the sensor turns on the therapeutic gene, thereby protecting the heart. In addition to its potential for patients with heart disease, the strategy might also prove useful for any condition in which tissues are susceptible to loss of blood supply, including stroke, shock, trauma and sepsis, the researchers said.

When administered to rat hearts several weeks before ischemia, the designer gene combination protected the heart from much of the damage that may weaken the organ and lead to failure, according to the researchers. Their report will appear in a forthcoming issue of Proceedings of the National Academy of Sciences and in the journal's online edition the week of Aug. 2, 2004.

The finding marks the first time a therapeutic gene complete with a built-in sensor that allows the gene to respond immediately to the condition it treats has been shown to work, said Victor J. Dzau, M.D., chancellor of health affairs at Duke University and an active physician-scientist at Duke. Such a therapy could offer a significant advance over available methods for treating heart patients, which are limited in their ability to provide treatment in the narrow window of time before irreversible heart damage occurs, he said. The work, led by Dzau at Brigham and Women's Hospital prior to his move to Duke in July, was supported by the National Institutes of Health and the Edna Mandel Foundation.

"While drugs that can protect heart mus
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-660-1306
Duke University Medical Center
2-Aug-2004


Page: 1 2 3

Related biology news :

1. Smart antibiotics may result from UCLA research
2. Smart bomb delivery destroys tumors in mice
3. Smart bandage diagnoses danger before infection takes hold
4. Smart carriers and tiny skin-deep medicine cabinets improve drug effectiveness against cancer, AIDS, other diseases
5. New Airways Smarts Ensure That Patients Get Plenty Of Oxygen
6. Research Aims At Nations First Smart Ground Water Regulations
7. Gene chips help gauge chemotherapys effectiveness in adult leukemia patients
8. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
9. Purdue study finds antioxidant protects metal-eating plants
10. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
11. Experimental smallpox DNA vaccine protects primates from lethal monkeypox

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... SAN FRANCISCO (PRWEB) , ... December 04, 2018 ... ... for life sciences and diagnostics companies, announces the placement of Michael Mercer at ... the commercial business strategy, Mr. Mercer will be based at Karius' headquarters in ...
(Date:11/29/2018)... ... 29, 2018 , ... ACEA Biosciences , now a ... Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium ... technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. ...
(Date:11/27/2018)... ... November 27, 2018 , ... Victrex has designed a new ... broader range of usage temperature compared to existing polymers such as PCTFE. At ... CTâ„¢ 200 for dynamic sealing applications where gases such as LNG* are stored ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... company backed by Siemens Healthineers and several healthcare VC firms announces at Distributed ... and making a history by purchasing tokens and obtaining its first radiology interpretations, ...
(Date:11/5/2018)... ... 2018 , ... 2Blades has completed a non-exclusive license agreement ... technology for applications in advancing research in epigenetic technology. , 2Blades holds ... 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in ...
(Date:11/3/2018)... DURHAM, N.C. (PRWEB) , ... November 01, 2018 , ... ... recognized by Inc. Magazine as one of the fastest-growing private companies in the United ... the Inc. 5000 list ranks private companies based on percentage revenue growth over the ...
(Date:10/31/2018)... ... October 30, 2018 , ... Myoscience, Inc. announced ... Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients and compares ... for managing pain after total knee replacement surgery (TKA). , The Myoscience iovera° ...
Breaking Biology Technology:
Cached News: